Health News Releases

  • Today April 21
An illustrative summary of the research outcome with Neu REFIX Beta glucan presents, several “Firsts
October 18, 2023 14:50
Neu REFIX β-glucan reduces muscle fibrosis in Duchenne muscular dystrophy MDX mice, in joint research with Dr. Yoshitsugu Aoki, NCNP, Tokyo, Japan.
Skeletal muscle fibrosis which leads to locomotor dysfunction in Duchenne Muscular Dystrophy (DMD) could be significantly reduced by oral consumption of Neu-REFIX beta 1,3-1,6 glucans alone for 45 day
October 18, 2023 10:10
Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=53617459&newsitemid=20231017266904&lan=en-US&anchor=Avania&index=1&md5=37cd0200f76b717153750b
October 18, 2023 09:00
Sanofi Bridging the Gap between the Homeless and Society via Futsal
Sanofi in Korea, the Korean subsidiaries of the global healthcare company Sanofi, hosted the founding ceremony of the homeless futsal club ‘Dream’ together with Dalpengyee, a nonprofit organization, t
October 17, 2023 15:55
MMI Expands Global Footprint with Entry into Asia Pacific Market
MMI, (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it will c
October 16, 2023 15:35
Merck to Present Latest Research from Oncology Portfolio at ESMO 2023
Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research on the company’s oncology portfolio addressing unmet needs across bladder, head and nec
October 15, 2023 12:01
Medisca Takes Additional Steps to Protect Its Innovative Technologies
Medisca has taken another step in protecting the strategic research and development (R&D) investments made decades ago that ultimately led to the industry-leading Medisca MAZ® mixer. The Medisca MAZ m
October 15, 2023 11:32
Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) confirmed
Copyrights - Sylvain Granjon
October 15, 2023 11:11
Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
Galderma, the emerging pure-play dermatology category leader, today hosts the first edition of its Liquid Live event in Dubai as a chance to discuss with clinicians the future of innovation in the fie
October 13, 2023 15:15
AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge
AstraZeneca announced today eight winners of the 2023 R&D Postdoctoral Challenge (https://openinnovation.astrazeneca.com/rd-postdoctoral-challenge.html) and agreed to fund their postdoctoral positions
AI Medical Service Inc. Signs Joint Research Agreement with Leading Vietnamese Medical Institution
October 13, 2023 14:40
AI Medical Service Inc. Signs Joint Research Agreement with Leading Vietnamese Medical Institution
AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Institute of Gastroenterology and
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
October 12, 2023 13:31
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and F
October 12, 2023 11:24
Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action in Atopic Dermatitis and Prurigo Nodularis
Galderma announced positive data from three pivotal phase III trials in atopic dermatitis and prurigo nodularis - ARCADIA 1 and 2 and OLYMPIA 1, respectively. The late-breaking data were presented tod
Care Access mobile research vehicle at Martha's Vineyard clinic. (Photo: Business Wire)
October 12, 2023 10:08
FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer VALOR trial.
October 11, 2023 15:38
Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced new five-year data from the open-label extension (OLE) of the Phase II clinical trial, whic
October 11, 2023 08:58
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and
October 10, 2023 15:59
Merck Presents New MAVENCLAD® (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced the presentation of new analyses from the MAVENCLAD® (cladribine tablets) MAGNIFY-MS study,
Masimo LiDCO® (Photo: Business Wire)
October 10, 2023 13:45
Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
Masimo (https://www.masimo.com/) (NASDAQ: MASI) today announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO® board-in-cable (BIC) module. The LiDCO BIC module is des
October 10, 2023 11:10
FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System
HistoSonics®, (www.histosonics.com), the manufacturer of the Edison® System and novel histotripsy therapy platforms, announced today the marketing authorization of its “Breakthrough” platform via the
October 09, 2023 15:05
Phase III Studies to Investigate Survodutide for People Living with Obesity and Overweight, with and without Diabetes, Cardiovascular Disease and Chronic Kidney Disease
Boehringer Ingelheim and Zealand Pharma A/S (NASDAQ: ZEAL) announced the initiation of three Phase III trials investigating survodutide (also known as BI 456906) for people living with overweight or o
October 06, 2023 14:30
Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years
Takeda (https://www.takeda.com/) (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE)
Caregivers play a critical role in the lives of millions of patients around the globe. (Photo: Busin
October 06, 2023 11:04
Merck Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Carers
Merck, a leading science and technology company, today announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to provide a training course on critical skills fo
October 05, 2023 11:38
Woman Reunited With the Nurse Who Helped Save Her Life 30 Years Ago
A woman was reunited this week with a nurse who saved her life 30 years ago as she volunteers for the same charity that her rescuers were from. In 1993, Catherine Conteh was enduring an agonizing f
October 04, 2023 15:05
EADV 2023: Galderma to Present New Data Showcasing Its Continued Leadership in Dermatology
Galderma, the emerging pure-play dermatology category leader, announced today it will be showcasing updates from across its broad and innovative dermatology portfolio at the 32nd European Academy of D
October 04, 2023 13:35
RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene Therapies, is pleased to announce the appointment of Dean J. Morris as the Chief Operations Of
October 04, 2023 11:10
Takeda Provides Update on EXKIVITY® (mobocertinib)
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA to
25 per page50 per page75 per page100 per page